[Cyclosporin].
Nojima
Yoshihisa
Y
Department of Medicine and Clinical Science, Gunma University Graduate School of Medicine.
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000037:antagonists & inhibitors; D000741:Anemia, Aplastic / Q000188:drug therapy; D001327:Autoimmune Diseases / Q000188:drug therapy; D001528:Behcet Syndrome / Q000188:drug therapy; D065095:Calcineurin Inhibitors; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology; D004347:Drug Interactions; D016903:Drug Monitoring; D004359:Drug Therapy, Combination; D018565:Food-Drug Interactions; D006084:Graft Rejection / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology; D016030:Kidney Transplantation
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents; D016572:Cyclosporine